These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5157541)

  • 21. [Studies on hypolipidemic agents. I. Syntheses and hypolipidemic activities of 2-(4'-chlorophenoxy)isobutyric acid derivatives (author's transl)].
    Miyoshi F; Kuroda H; Hiraoka K; Fukami H; Onishi K
    Yakugaku Zasshi; 1974 Mar; 94(3):387-96. PubMed ID: 4859114
    [No Abstract]   [Full Text] [Related]  

  • 22. Antilipolytic effect of tiadenol and clofibrate in rat epididymal fat pads.
    Bacciarelli C; Boni P; Castellucci A
    Farmaco Prat; 1978 Sep; 33(9):401-6. PubMed ID: 218836
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of SaH 42-348, an analog of clofibrate, on lipid metabolism in rats.
    Kritchevsky D; Tepper SA
    Arzneimittelforschung; 1973 Jun; 23(6):858-9. PubMed ID: 4740771
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of administration of clofibrate and clofenapate on the content and distribution of ubiquinone in rat tissues.
    Krishnakantha TP; Kurup CK
    Indian J Biochem Biophys; 1974 Mar; 11(1):51-3. PubMed ID: 4435808
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of hypolipidemic drugs on hepatic CoA.
    Halvorsen O
    Biochem Pharmacol; 1983 Mar; 32(6):1126-8. PubMed ID: 6838659
    [No Abstract]   [Full Text] [Related]  

  • 26. Azoreduction of dimethylaminoazobenzene (DAB) in primary cultures of rat hepatocytes. Effect of hypolipidemic agents.
    Stoddart AM; Levine WG
    Drug Metab Dispos; 1990; 18(1):36-41. PubMed ID: 1970775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amides of beta-(4-chlorophenoxy)-alpha-phenyl-ethylamines are inhibitors of cholesterol biosynthesis in vitro.
    Rossi S; Diamantini G; Pescador R
    Farmaco; 1989 Mar; 44(3):315-21. PubMed ID: 2775418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hypocholesteremic drugs on tumor-bearing mice.
    Kabara JJ; Chapman BB; Borin BM
    Proc Soc Exp Biol Med; 1972 Jan; 139(1):100-4. PubMed ID: 5007444
    [No Abstract]   [Full Text] [Related]  

  • 30. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
    Kokatnur MG; Malcom GT
    Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic effects of clofibrate on experimental animals.
    Bedö M; Kramer M; Blaskovits A; Gefferth G; Tarjan R
    Arzneimittelforschung; 1978; 28(7):1076-80. PubMed ID: 582692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
    Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
    Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
    [No Abstract]   [Full Text] [Related]  

  • 33. Decrease of superoxide dismutase and glutathione peroxidase in liver of rats treated with hypolipidemic drugs.
    Ciriolo MR; Mavelli I; Rotilio G; Borzatta V; Cristofari M; Stanzani L
    FEBS Lett; 1982 Aug; 144(2):264-8. PubMed ID: 7117540
    [No Abstract]   [Full Text] [Related]  

  • 34. Dietary clofibrate inhibits induction of hepatic antioxidant enzymes by chronic estradiol in female ACI rats.
    Mesia-Vela S; Sanchez RI; Reuhl KR; Conney AH; Kauffman FC
    Toxicology; 2004 Aug; 200(2-3):103-11. PubMed ID: 15212807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of acute-phase synthesis of fibrinogen by a hypolipidemic drug (clofibrate).
    Pickart L
    Int J Tissue React; 1981 Jun; 3(2):65-72. PubMed ID: 7327616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of clofibrate (ethyl-p-chlorophenoxy isobutyrate), M-451 (bis-p-chlorophenoxy-acetylurea) and phenobarbital on experimental liver damage in rats].
    Elek S; Borsy J; Maderspach A; Polgári I; Osváth Z; Jámbor E
    Acta Pharm Hung; 1974 Mar; 44(1):30-6. PubMed ID: 4849902
    [No Abstract]   [Full Text] [Related]  

  • 37. Clofibrate prevents and reverses the hemodynamic manifestations of hyperthyroidism in rats.
    Rodríguez-Gómez I; Cruz A; Moreno JM; Soler A; Osuna A; Vargas F
    Am J Hypertens; 2008 Mar; 21(3):341-7. PubMed ID: 18219302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative biochemical and ultrastructural study of the hepatic response induced in the rat by 2 hypolipemic agents: clofibrate and itanoxone].
    Gendre PM; Marcelon G; Delhon A; Lauressergues H; Fauran F
    J Pharmacol; 1984; 15(2):209-22. PubMed ID: 6738078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of clofibrate on acetyl-CoA carboxylase activity in hepatocytes.
    Harkins JB; Yates RD
    Z Zellforsch Mikrosk Anat; 1971; 119(3):321-5. PubMed ID: 5569050
    [No Abstract]   [Full Text] [Related]  

  • 40. Rat hepatocyte peroxisomes: ultrastructural alterations following cessation of chronic dietary clofibrate administration.
    Hartman HA; Tousimis AJ
    Experientia; 1969 Dec; 25(12):1248-9. PubMed ID: 5365841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.